Site Members can sign up for company wide alerts
Lawsuit Overview
January 05, 2023 - An investor in shares of BioLineRx Ltd. (NASDAQ: BLRX) filed a lawsuit in the U.S. District Court for the District of New Jersey yver alleged violations of Federal Securities Laws by BioLineRx Ltd. in connection with certain allegedly false and misleading statements made between February 23, 2021 and September 19, 2022. Israel based BioLineRx Ltd., a clinical-stage ...
You must register (for free) or login to view the entire case.